These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8149949

  • 1. Comparative pharmacokinetics of silipide and silymarin in rats.
    Morazzoni P, Montalbetti A, Malandrino S, Pifferi G.
    Eur J Drug Metab Pharmacokinet; 1993; 18(3):289-97. PubMed ID: 8149949
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients.
    Schandalik R, Gatti G, Perucca E.
    Arzneimittelforschung; 1992 Jul; 42(7):964-8. PubMed ID: 1329780
    [Abstract] [Full Text] [Related]

  • 3. Comparative bioavailability of Silipide, a new flavanolignan complex, in rats.
    Morazzoni P, Magistretti MJ, Giachetti C, Zanolo G.
    Eur J Drug Metab Pharmacokinet; 1992 Jul; 17(1):39-44. PubMed ID: 1499596
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex (silipide) in healthy volunteers.
    Gatti G, Perucca E.
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):614-7. PubMed ID: 7874377
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.
    Zhu HJ, Brinda BJ, Chavin KD, Bernstein HJ, Patrick KS, Markowitz JS.
    Drug Metab Dispos; 2013 Sep; 41(9):1679-85. PubMed ID: 23835761
    [Abstract] [Full Text] [Related]

  • 14. Determination of active component in silymarin by RP-LC and LC/MS.
    Ding T, Tian S, Zhang Z, Gu D, Chen Y, Shi Y, Sun Z.
    J Pharm Biomed Anal; 2001 Aug; 26(1):155-61. PubMed ID: 11451653
    [Abstract] [Full Text] [Related]

  • 15. Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2).
    Miranda SR, Lee JK, Brouwer KL, Wen Z, Smith PC, Hawke RL.
    Drug Metab Dispos; 2008 Nov; 36(11):2219-26. PubMed ID: 18687803
    [Abstract] [Full Text] [Related]

  • 16. Relative Bioavailability of Silybin A and Silybin B From 2 Multiconstituent Dietary Supplement Formulations Containing Milk Thistle Extract: A Single-dose Study.
    Li WY, Yu G, Hogan RM, Mohandas R, Frye RF, Gumpricht E, Markowitz JS.
    Clin Ther; 2018 Jan; 40(1):103-113.e1. PubMed ID: 29273470
    [Abstract] [Full Text] [Related]

  • 17. Studies on the antioxidant and free radical scavenging properties of IdB 1016 a new flavanolignan complex.
    Comoglio A, Leonarduzzi G, Carini R, Busolin D, Basaga H, Albano E, Tomasi A, Poli G, Morazzoni P, Magistretti MJ.
    Free Radic Res Commun; 1990 Jan; 11(1-3):109-15. PubMed ID: 2074043
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic interaction between oltipraz and silymarin in rats.
    Kang MK, Bae SK, Kim JW, Lee MG.
    J Pharm Pharm Sci; 2009 Jan; 12(1):1-16. PubMed ID: 19470289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.